Anti-ovulatory
and Abortifacient Potential of the Ethanolic Extract of Henna Roots in Rats
S Rani*, R Manavalan and D Kilimozhi
Department of Pharmacy, Annamalai
University, Annamalai Nagar - 608002, Tamil Nadu. India.
ABSTRACT
The rise in population in the
developing world is over whelming and this intensifies the need for effective
birth control measures. The synthetic agents available today for fertility
control produce severe side effects. Such as hormonal imbalance, hypertension,
increased risk of cancer and weight gain. Thus there is a need to replace these
agents by safe and effective agents such as plants based contraceptive agents.
Therefore, the present study was
under taken to explore the abotifacient and antiovulatory activity of ethanol
extract of henna roots. Thus, the successive ethanolic extract showed promising
strong abotifacient and antiovulatory activity was observed at dose level of
400mg/kg body weight. Histological studies were carried out to confirm this
effect.
KEY WORDS: Abortifacient, ovulation,
contraception.
INTRODUCTION
The henna plant Lawsonia inermis Linn is a fragrant
shrub native to Asia and northern Africa. The word henna which means “to become
queen” is indicative of something highly elegant. The plants extract or its
purified compounds exhibit a variety of biological activities. Such as anticomplementary
activity (Handa et al, 1997), dihydroorotate dehydrogenase inhibitory activity,
(Knecht et al;2000), macrophage stimulating activity as result of stimulation
of secretion of granulocyte macrophage colony stimulating factor (GM-CSF)
(Wagner et al, 1988), antimicrobial activity (Malekzadeh, 1968; Abd-el-Malek et
al, 1973), antisickling activity (Chang and Suzuka, 1982; Clarke et al, 1986),
hepatoprotective activity (An-aad et al,1992), cytotoxic activity (Ali and
Grever,1998), anti-inflammatory, antipyretic and analgesic activities (Ali et
al, 1995). In the light of the previous activities, the study ours examined
antiovulatory and abortifacient activities of the ethanolic extract of henna
roots.
MATERIAL AND METHODS:
Plant collection and preparation of the extract:
The fresh henna roots were
collected from Cuddalore district. Tamil Nadu. They were identified and
authenticated by Dept of Botany, Annamalai University, Chidambaram. A Specimen
sample of the same was preserved at the herbarium of the Department of Botany,
Annamalai University with Voucher no 12456, for future reference.
The roots were isolated and
chopped into small pieces. Next, they were dried under shade at room
temperature for seven days. The dried
roots were powdered, passed through sieve (coarse 10/44) and extracted with
ethanol using soxhlet extractor (Shivalinagappa H et al, 2001). The combined extracts were concentrated of
40º C to obtain dark brownish yellow residue.
The yield obtained from this process was found to be 25.5%w/w.
Experimental animals:
Colony bred virgin female adult
Wister strain rats were used in all experiments. All animals were housed in standard cages in
uniform conditions (12 hours dark and 12 hours light cycle) and at room
temperature. Animals were fed on pellet
and tap water ad libitum. Animal
Table 1: Effect of the ethanolic extract of henna
roots on the duration of the different phases of the estrous cycle in rats.
|
Group |
Treatment |
Dose (mg/kg) |
No. of days in proestrous |
No. of days in estrous |
No. of days in metestrous |
No. of days in diestrous |
|
1. |
Control (1%Tween80) |
-- |
2.062±0.026 |
3.095±0.038 |
3.923±0.032 |
5.215±.0066 |
|
2. |
Ethanolic extract |
200 |
7.065±0.055b |
1.233±0.044b |
1.602±0.070b |
5.135±0.036b |
|
3. |
Ethanolic extract |
400 |
7.085±0.035a |
0.056±0.223a |
0.740±0.015a |
6.322±0.077a |
Values in tables are represented in Mean ± SEM (n = 6)
a = P <0.02 is significant when compared with
control groups, b = P<0.05 is significant when compared with control groups.
Table 2:
Effect of the ethanolic extract of henna roots on the ovarian weight and
cholesterol level.
|
Group |
Treatment |
Dose (mg/kg) |
Ovarian weight in mg/100g
body weight |
Cholesterol level in ovary
(mg/50mg) |
|
1. |
Control (1% Tween80) |
--- |
40.357±0.096 |
0.378±0.032 |
|
2. |
Ethanolic extract |
200 |
30.393±0.135b |
1.058±0.017 |
|
3. |
Ethanolic extract |
400 |
34.188±0.062a |
0.465±0.011 |
Values in tables are represented in Mean ± SEM (n = 6)
a = P<0.02 is significant when compared with control
groups, b = P<0.05 is significant when compared with control groups.
Table 3:
Abortifacient effect of ethanolic root extract of henna on rats when fed
orally between days 6 to day 15 of pregnancy.
|
Treatment |
Dose (mg/kg) |
Average No. of foetus |
Average No. of rats aborted |
Abortion in % |
|
Control (1% Tween80) |
- |
9.83 ± 1.25 |
6/0 |
0% |
|
Ethanolic extract |
200 |
6.17 ± 0.87b |
6/0 |
0% |
|
Ethanolic extract |
400 |
- |
6/6 |
100% |
Values in tables are represented in Mean ± SEM (n = 6),
b = P<0.05 when compared with control.
were handled in this study as per the
International Guidelines for Handling Experimental Animals (OPPT guidelines).
Antiovulatory activity:
Vaginal smear from each rat was examined dally for 15
days, and those rats exhibited three regular cycles (12) were
included in the study. The selected were
divided into three groups of six animals each.
Drugs and vehicle were started in estrous phase and administrated
orally; daily for 15-day treatment was to cover three regular estrous
cycles. Group I received vehicle only
(1% tween 80 p.o daily) and served as control.
Groups II and group III received ethanolic extract 200 and 400mg/kg
respectively. The 15-day treatment was to cover three regular estrous cycles.
Vaginal smear from each animal was observed every morning between 7 to 10
am. On 16th day, 24 hrs
after the last treatment, the animals from each group were sacrificed. Ovaries and uteri were dissected out, freed
from extra deposition and weighed on sensitive balance (Precisa, XB
series). One other ovary was fixed in
10% formalin buffer for histological study.
Abortifacient activity:
Proven female Wistar rats weighing between
145 to 200g were selected and left over night with males of proven fertility in
ratio of 2.1 in the proestrous phase day 1 at the pregnancy was confirmed by
the presence of spermatozoa in the vaginal smear. The pregnant rats divided into three groups
of animals each. Group I received
vehicle only (1% tween 80 per oral daily) and served as control. Group II and group III received ethanolic
extract at 200 and 400mg/kg per orally daily respectively. The extracts were administrated orally
through gastric gavages from the 6th to 15th day of pregnancy (period of organogenesis). The animals were laprotomised after cervical
dislocation of the on 19th day of pregnancy. Both horns at the uterus were observed for
the number of implantation sites, resorptions, and dead and alive fetuses.
(12), (13), (14).
Statistical Analysis:
The data was analyzed using one way ANOVA
followed by the Tukey-Kramer multiple comparison post-test. A P value < 0.05
was considered to be statistically significant.
RESULT:
Dose fixation:
Dose fixation was carried out by staircase
method on Swiss mice (80 - 100gm).All the extracts were mixed in 1% of tween 80
and dissolved in distilled water, and they were administrated to mice orally by
means intra gastric catheter. It was
observed that none of the animal was found to be lethal even at the dose of
4000mg/kg body weight. Therefore, we
selected 1/10th & 1/20thof the dose was selected for
the study.
Ethanolic extract at 200mg and 400mg/kg
caused a significant decreased in the duration of the estrous and metestrous
phases, no change in the duration diestrous phase, and significant increase in
the duration of the proestrous phase, compared with control group. (Table1)
Ethanolic extract at 200mg and 400mg/kg
significantly decreased the weight of ovaries, compared with control group
(Table-2). An increase in preovulatory
follicles and atretic follicles was seen in the treated groups. A highly
significant increase in ovarian cholesterol level was observed at 200mg /kg
compared with control group. At 400 mg/kg ethanolic extract showed a highly
significant abortifacient effect. At 200mg/kg, ethnolic extract did not show
any abortifacient activity.
DISCUSSION:
Many crude extracts and active principles
derived from medicinal plants were evaluated for their anti fertility effects
in animal models. Many changes occur in the ovary during the estrous cycle.
During the maturation of pre ovulatory follicles, ovulation taken place under
the combined and balanced influence of ovarian and extra ovarian hormone. Imbalance in this hormone leads to
irregulatory in the ovarian functions and duration of the estrous cycle. (16,
17)
The estrous cycle in the rats treated with
extract (200 and 400mg/kg) showed a decrease in the duration estrous and
metestrous phases. It was also characterized by a prolongation of proestrous
phase. The prolongation of proestrous phase indicates that maturation of the
follicle in the preovulatory phase was delayed, leading to non-maturation of
graiffian follicle Non-availability of matured graffian follicle was indicated
by reduction in the estrous and metaestrous phases. Therefore ovulation was
inhibited. The result was further supported by our histopathological studies in
which the transverse section of the ovary showed the presence of primary or
developing follicles. The presence of increased atretic follicles in the rats
treated with ethanolic extract, compared with control rats, indicates that the
extract promotes the degeneration of preovulatory follicles. Cholesterol is the
precursor for the steroidogenesis of ovarian endocrine tissues. The significant
increase in ovarian cholesterol in the treated groups (200mg/kg) indicates that
cholesterol is not used for steroidogenesis. But 400mg/kg dose did not show a
similar effect indicating that it occurs only lower
dose. Abortion refers to the premature expulsion of the products of conception
from the uterus. Abortion may be to
maternal exposure to chemicals, which can disrupt pregnancy cause detachment of
the embryo (Medeiros RM et al,
2000). Ethanolic extract at 400mg/kg showed 100%
abortificient activity.
From the results of this investigation it
may be concluded that henna root extract a highly significant decrease in the
duration of estrous and metaestrous phase and increase the duration of the
proestrotus phase was seen. In addition, highly significant decrease in ovarian
weight and increase the cholesterol level, when compared with the control group
was noted. This finding indicates the extract of henna roots produces
inhibition of ovulation. The result of
administration of extract to the pregnant rats during organogenesis shows that
the extract is abortificent only at higher dose of 400mg/kg. So all this observation
suggests that the henna roots extract produced antiovulatory and abortificient
activity. Further studies is necessary
to confirm the potent active components
for the observed effect and exact
mechanism of action, work on the
semi purified total extract is in
progress to validate the present findings.
REFERENCES:
1. Handa G.Kapil A., Sharma S., and Singh J.
(1997), Lawnermis acid a new anticomplementary triterpenoid from Lawsonia inermis seeds. Indian J. Chem.,
Sect. B.36, 252-256.
2. Knecht W., Henseling J., and Loffler M.
(2000), Kinetics of inhibition of human
and rat dihydroorotate dehydrogenase by atovaquone, lawsone derivatives,
brequinar sodium and polyporic acid. Chem. Biol. Interact. 124, 61-76.
3. Wagner H., Kreher B., and Jurcic K. (1988).
In vitro stimulation of human granulocytes and lymphocytes by pico- and
femtogram quantities of cytostatic agents. Arzneim. Forsch. 38, 273-275.
4. Malekzadeh F. (1968), antimicrobial activity
of Lawsonia inermis L. Applied Microbiol 16, 663-664.
5. Abd-el- Malek Y.A., El-Leithy M.A., Reda
F.A., and Khalil M. (1973). Antimicrobial principles in leaves of Lawsonia inermis L. Zentralbl.
Bakteriol. Parasitenkd Infektionskr Hyg. 128, 61-67.
6. Chang H., and suzuka S.E., (1982). Lawsone
(2-OH-1,4- naphthoquinone) derived from the henna plant increases the oxygen
affinity of sickle cell blood. Bio-chem. Biophys. Res. Commun. 107, 602-608.
7. Clarke D.T., Jones G.R., and Martin M.M
(1986), The anti – sickling drug lawsone (2-OH-1,4 – naphtha-quinone) Protects
sickled cells against membrane damage, Biochem. Biophys, Res. Commun.139, 780 –
786.
8. Anaad K.K., Singh B., Chand D., and Chandon
B.K. (1992). An evaluation of Lawsonia alba extract as hepatoprotective agent.
Planta Med. 58, 22-25.
9. Ali M., and Grever M.R. (1998). A cytotoxic
naphthoquinone from Lawsonia inermis.
Fitoterapia LXIX ( 2 ) ,1810-1813.
10. Ali B H, Bashir A.K., and Tanira M.O.
(1995), anti-inflammatory, antipyretic, and analgesic effects of Lawsonia
inermis L (Henna) in rats. Pharmacology 51, 356-63.
11. Shivalinagappa. H., Satyanaryan. ND., and
Purohit. MG. (2001). Antimplantation and pregnancy interruption efficacy of Rivea hypocrateriformis in the rat. J
Ethnopharmacol; 74: 245-9.
12. -60. Hafez ES. (1970). Reproduction in
breeding techniques for laboratory animals. Philadelphia: Leaand febiger.
13. Medeiros RM., Gorniak SL., and Guerra JL.
(2000). Fetotoxicity and Reproductive effects of monocrotaline in pregnant
rats. J Ethnopharmacol; 69: 181-8.
14. Feranada CG. Almedia., and Lone P. Lemonica
(2000). The toxic effects of Coleus
barbatus B on the different periods of pregnancy in rats. J Ethnopharmacol;
73: 53
15. Nath D., Sethi N., Singh RK., and Jain AK.
(1992). Commonly used Indian abortifacient plants with special reference to
teratologic effects in rats. J. Ethnopharmacol; 36: 147-54.
16. Prakash AO., and Mathur R. (1979). Studies
on oestrous cycle of the albino rats: Response to Embelia ribes extracts. Planta Medica; 36: 131-41.
17. Shivalinagppa H., Satyanarayan ND., Purohit
MG., Sharanabasappa A., and Patil SB. (2002). Effect of ethanol extract of Rivea hypocrateriformis on the estrous
cycle of the rat. J Ethnopharmacol; 82: 11-7.
18. Circosta C., Sanogo E., and Occhiuto F.
(2001). Effects of Calotropis procera
on oestrous cycle and on oestrogenic functionality in rats. Farmaco; 56: 373-8.
Received on 08.08.2009
Accepted on 16.08.2009
© A &V Publication all right reserved
Research J. Pharmacology and
Pharmacodynamics 2009; 1(1): 18-20